Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by goldn1on Sep 25, 2019 10:38pm
122 Views
Post# 30165503

RE:Don't lose sight of what this company has achieved and 17

RE:Don't lose sight of what this company has achieved and 17
Galaxy:

The money is meaningless without a successful Phase II. If the cancer side of TLT isn't succesful, the company will eventually go BK as the laser division as always lost money. They will simply burn thru the PP money with slalaries and losses from the laser side until the close up shop.

Some people on this board feel TLT will 100% be successful and the new SOC in bladder cancer as well as several other indications. I hope that ends up happening, but the stock price and lack of real interest from investors, patients and the media seems to be telling us a different story.

I expected the price to struggle for a while with the PP done at 30 cents, but even PP investors must not be too happy. Somehow, 15 million short shares were covered w o the stock moving up at all, it actually came down. So some person and/or instution has a reason to sell TLT at a big loss. I hope they don't know something we don't.  It is nice to have shareholders who believe in the company, but I think a few have gone a bit too far and won't even look at the reality which is 22 cents after two cancer free patients. There definately is something missing...


G1
Bullboard Posts